Pablo E Vivas-Mejía

11PUBLICATIONS
18CO-AUTHORS
Molecular targetsAutoimmunityPredictive and prognostic markersMicro- and nanosystemsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 27, 2025
Molecular Basis of Simalikalactone D Sensitivity in Triple-Negative Breast Cancer Cells.

Annelis O Sánchez-Álvarez, Joshua Nieves-Reyes, Gabriel Borges-Vélez

|Jul 30, 2025
Synthesis and Biological Evaluation of Herceptin-Conjugated Liposomes Loaded with Lipocalin-2 siRNA for the Treatment of Inflammatory Breast Cancer.

Marienid Flores-Colón, Mariela Rivera-Serrano, Esther A Peterson-Peguero

|May 14, 2025
Upregulation of MMP3 Promotes Cisplatin Resistance in Ovarian Cancer.

Mariela Rivera-Serrano, Marienid Flores-Colón, Fatima Valiyeva

|Oct 26, 2024
Effect of Cyclodextrins Formulated in Liposomes and Gold and Selenium Nanoparticles on siRNA Stability in Cell Culture Medium.

Betzaida Castillo Cruz, Sandra Chinapen Barletta, Bryan G Ortiz Muñoz

|Apr 13, 2024
MicroRNA Expression Profiles in Human Samples and Cell Lines Revealed Nine miRNAs Associated with Cisplatin Resistance in High-Grade Serous Ovarian Cancer.

Marienid Flores-Colón, Mariela Rivera-Serrano, Víctor G Reyes-Burgos

|Dec 11, 2022
Increased Expression of the RBPMS Splice Variants Inhibits Cell Proliferation in Ovarian Cancer Cells.

Robert J Rabelo-Fernández, Ricardo A Noriega Rivera, Yasmarie Santana Rivera

Pageof 2

Frequent Collaborators

3 joint publications

Yasmarie Santana Rivera

3 joint publications

Blanca Quiñones-Díaz

3 joint publications

Robert J Rabelo-Fernández

2 joint publications

Mariela Rivera-Serrano